The Doherty Institute is governed by the Doherty Council, which comprises of senior level executives from the University of Melbourne and the Royal Melbourne Hospital and the Director of the Institute.
The Doherty Council
Professor Sharon Lewin - Director
Leading infectious diseases expert Professor Sharon Lewin is the inaugural Director of the Doherty Institute. Sharon is also a Professor of Medicine at The University of Melbourne and a National Health and Medical Research Council (NHMRC) Practitioner Fellow. As an infectious diseases physician and basic scientist, her laboratory focuses on basic, translational and clinical research aimed at finding a cure for HIV and understanding the interaction between HIV and hepatitis B virus. She has published over 260 publications and is funded by the NHMRC, the National Institutes of Health, The Wellcome Trust, the American Foundation for AIDS Research and multiple commercial partnerships. Sharon was local co-chair for the International AIDS Conference held in Melbourne in 2014. She is chair of the Ministerial Advisory Committee for Blood Borne Viruses and Sexually Transmitted Infections, the peak advisory committee to the Federal Minister for Health; a member of the NHMRC Council; an elected member of the Governing Council of the International AIDS Society representing the Asia-Pacific region; and was a foundation council member of the Australian Academy for Health and Medical Research. She was named Melburnian of the Year in 2014, and in 2015, was awarded the Peter Wills Medal by Research Australia.
Professor Shitij Kapur – Dean of the Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne
Professor Shitij Kapur’s main research interest is in understanding Schizophrenia and its treatment. He has used brain imaging, animals models and clinical studies which have led to a better understanding of antipsychotic action, its relationship to brain dopamine receptor blockade, the role of appropriate dosing of these drugs and has led to the development of the ‘salience’ framework of psychosis and the ‘early onset’ hypothesis if antipsychotic action. Shitij has published 300 peer-reviewed papers, his work has received over 25,000 citations as he has made numerous presentations worldwide. He serves in advisory capacity to public charities and pharmaceutical companies and has received national and international awards including the AE Bennett Award of the Society for Biological Psychiatry, Paul Janssen Award of the CINP. He is a Distinguished Fellow of the American Psychiatric Association and the Fellow of the Academy of Medical Sciences, UK, and Fellow of King’s College London, UK. He led NEWMEDS, an EU-wide Innovative Medicines Initiative and currently leads STRATA, a UK-wide program to enhance stratified medicine strategies in psychiatry.
Professor James McCluskey – Deputy Vice-Chancellor (Research), University of Melbourne
Professor James McCluskey is the Deputy Vice-Chancellor (Research) at the University of Melbourne, appointed in March 2011 and led the development of the Doherty Institute. Prior to this he was the Pro Vice-Chancellor, Research Partnerships and Chair of Microbiology and Immunology. James trained in Perth as a physician and pathologist. He spent four years at the National Institutes of Health in the USA. On returning to Australia in 1987 he worked at Monash University until 1991 before joining Flinders University and the Australian Red Cross Blood Service. James joined the University of Melbourne in 1997 and has an international reputation for his research in basic and clinical immunology and is recognised for his leadership in the field of human leukocyte antigens (HLA) and the major histocompatibility complex (MHC). He has consulted for the Australian Red Cross for more than 20 years and is Editor-in-Chief of the international immunogenetics journal, Tissue Antigens. He is on the Board of Directors of the Walter and Eliza Hall Institute, Florey Neuroscience Institutes, Bionics Institute and is Chair of the Nossal Institute Council and the Board of Nossal Institute Limited.
Professor Christine Kilpatrick – Chief Executive, Royal Melbourne Hospital
Christine Kilpatrick commenced as Chief Executive , Melbourne Health in May 2017. Previous appointments include Chief Executive, The Royal Children’s Hospital from 2008 – 2017, Executive Director Medical Services, Melbourne Health and Executive Director Royal Melbourne Hospital, Melbourne Health. Prior to these appointments she was a neurologist, specialising in epilepsy.
Christine has held several external appointments including Chair Victorian Quality Council in Healthcare and Member of the Women’s and Children’s Health Board. She was awarded a Centenary medal in 2003 and in 2014 was included in the Victorian Honour Roll of Women.
Professor Ingrid Winship – Executive Director Research, Royal Melbourne Hospital
Professor Ingrid Winship was appointed as the Executive Director Research for Melbourne Health and the Inaugural Chair of Adult Clinical Genetics at the University of Melbourne in November 2006. Ingrid graduated from the University of Cape Town in 1981 then completed postgraduate training in genetics and dermatology before combining an academic position at the University with a clinical position at the Groote Schuur Hospital from 1989-1994. In 1994, she moved to New Zealand to take an academic position at the University of Auckland where she later became Professor of Clinical Genetics. She was also Clinical Director of the Northern Regional Genetic Service in Auckland, which she initiated in 1995. In her last five years in Auckland she was Associate Dean for Research in the Faculty of Medicine and Health Sciences. Ingrid is currently a member of the Victorian Cancer Agency and on the Board of the Walter and Eliza Hall Institute. She is on the steering committee of the Melbourne Genomic Health Alliance, Scientific Advisor to the Human Variome Project and a member of the Strategic Advisory Council of the Kinghorn Centre for Clinical Genomics. She is a member of the Australian Health Ethics Committee of the National Health and Medical Research Council (NHMRC).